Paid Clinical Trials in Los Angeles, CA

As of September 2026, 1,961 paid clinical trials are recruiting in Los Angeles, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 4, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,723 clinical trials

Get a weekly email when new trials open in Los Angeles, CA.

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

for Wound Heal

Sites in Los Angeles, Tarzana +15 more locations

Sponsor: ConvaTec Inc.

Sex: All·Age: 18+

Code: NCT06616844·Recruiting·Listed Sep 2024

Apply to this trial

A Study of MGC026 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles +6 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06242470·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

for Advanced/Metastatic Solid Tumors

Sites in Los Angeles +5 more locations

Sponsor: DualityBio Inc.

Sex: All·Age: 18+

Code: NCT07141706·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

for Metastatic Non-Squamous Non-Small Cell Lung Cancer

Sites in Los Angeles +6 more locations

Sponsor: CatalYm GmbH

Sex: All·Age: 18+

Code: NCT07098988·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for B-cell Acute Lymphoblastic Leukemia

Sites in Los Angeles, Duarte +9 more locations

Sponsor: Vironexis Biotherapeutics Inc.

Sex: All·Age: 13 - 90

Code: NCT06533579·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

for Diffuse Astrocytoma, IDH-Mutant

Sites in Los Angeles, Beverly Hills +5 more locations

Sponsor: Neonc Technologies, Inc.

Sex: All·Age: 18+

Code: NCT06047379·Phase 1, Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for Tumor Skin

Sites in Los Angeles, Stanford +6 more locations

Sponsor: Obsidian Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06060613·Phase 1, Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

for Glomerulonephritis, IGA

Drug: Iptacopan

Sites in Los Angeles +8 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 99

Code: NCT06797518·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

for Chronic Primary Immune Thrombocytopenia (ITP)

Sites in Los Angeles +2 more locations

Sponsor: Kedrion S.p.A.

Sex: All·Age: 18 - 70

Code: NCT07059000·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes

for Discogenic Low Back Pain

Sites in Los Angeles, Beverly Hills +7 more locations

Sponsor: Aclarion

Sex: All·Age: 18 - 70

Code: NCT06661850·Recruiting·Listed Oct 2024

Apply to this trial

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

for Chronic Kidney Disease (CKD)

Sites in Los Angeles, Orange +5 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18 - 70

Code: NCT05106387·Recruiting·Listed Nov 2021

Apply to this trial

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

for Friedreich Ataxia

Sites in Los Angeles +5 more locations

Sponsor: Larimar Therapeutics, Inc.

Sex: All·Age: 2 - 60

Code: NCT06447025·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles, Duarte +7 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT05981703·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Study of FID-022 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles, Duarte +1 more location

Sponsor: Fulgent Pharma LLC.

Sex: All·Age: 18+

Code: NCT06694480·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

for Gastroesophageal Junction

Sites in Los Angeles +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06445972·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

for Prostatic Neoplasms, Castration-Resistant

Sites in Los Angeles, La Jolla +3 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06353386·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

for Gastroesophageal Junction

Sites in Los Angeles +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06469944·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

for Esophageal Squamous Cell Carcinoma

Sites in Los Angeles +3 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05319730·Phase 1, Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery

for Hemostasis

Sites in Los Angeles +5 more locations

Sponsor: Ethicon, Inc.

Sex: All·Age: 22+

Code: NCT06664788·Recruiting·Listed Oct 2024

Apply to this trial

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

for Small Cell Lung Cancer

Sites in Los Angeles +1 more location

Sponsor: SciTech Development, Inc.

Sex: All·Age: 18+

Code: NCT06922539·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

for X-linked Retinoschisis

Sites in Los Angeles, La Jolla +16 more locations

Sponsor: Atsena Therapeutics Inc.

Sex: All·Age: 6+

Code: NCT05878860·Phase 3·Recruiting·Listed May 2023

Apply to this trial

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles +1 more location

Sponsor: CStone Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06741644·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

NEO100 and High-Grade Meningioma

for Residual, Progressive or Recurrent Grade II or III Meningioma

Sites in Los Angeles, Santa Monica +3 more locations

Sponsor: Neonc Technologies, Inc.

Sex: All·Age: 12+

Code: NCT05023018·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

Sites in Los Angeles +5 more locations

Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05985655·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications.

for Frequency and Type of Medical Adhesive-Related Skin Injury

Sites in Los Angeles, Torrance +1 more location

Sponsor: Global Biomedical Technologies, LLC

Sex: All·Age: 18+

Code: NCT06717308·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

for Squamous Non-small-cell Lung Cancer

Sites in Los Angeles, Fullerton +6 more locations

Sponsor: Alentis Therapeutics AG

Sex: All·Age: 18+

Code: NCT06747585·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for Solid Tumors

Sites in Los Angeles +2 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT05471856·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

Abbott Structural Heart Device Registry

for Heart Diseases

Sites in Los Angeles +12 more locations

Sponsor: Abbott Medical Devices

Sex: All·Age: All ages

Code: NCT06590467·Recruiting·Listed Sep 2024

Apply to this trial

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

for Extensive Stage Small Cell Lung Cancer

Drug: Tarlatamab

Sites in Los Angeles +5 more locations

Sponsor: Amgen

Sex: All·Age: 18+

Code: NCT06598306·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Study of WAL0921 in Patients With Glomerular Kidney Diseases

for Diabetic Nephropathies

Sites in Los Angeles +8 more locations

Sponsor: Walden Biosciences

Sex: All·Age: 18 - 75

Code: NCT06466135·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

for Solid Tumor, Adult

1 location in Los Angeles

Sponsor: BioInvent International AB

Sex: All·Age: 18+

Code: NCT04219254·Phase 1, Phase 2·Recruiting·Listed Jan 2020

Apply to this trial

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

for Advanced Malignant Solid Neoplasm

Sites in Los Angeles +2 more locations

Sponsor: RasCal Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT04678648·Phase 1·Recruiting·Listed Dec 2020

Apply to this trial

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

for Pancreatic Ductal Adenocarcinoma

Sites in Los Angeles, Palo Alto +7 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT06562192·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for High-grade Serous Ovarian Carcinoma (HGSOC)

Sites in Los Angeles +4 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06476808·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

for Skin Laxity (Submental and Neck)

Sites in Los Angeles +4 more locations

Sponsor: CLASSYS Inc.

Sex: All·Age: 30 - 65·Accepts healthy volunteers

Code: NCT07229430·Recruiting·Listed Nov 2025

Apply to this trial

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles +4 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06625593·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

REMASTer: REcurrent Brain Metastases After SRS Trial

for Brain Metastases

Sites in Los Angeles +7 more locations

Sponsor: Monteris Medical

Sex: All·Age: 18+

Code: NCT05124912·Recruiting·Listed Nov 2021

Apply to this trial

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

for Hepatoblastoma

Sites in Los Angeles, Orange +2 more locations

Sponsor: Eureka Therapeutics Inc.

Sex: All·Age: 1 - 21

Code: NCT04634357·Phase 1, Phase 2·Recruiting·Listed Nov 2020

Apply to this trial

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles +4 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06233942·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

for Atopic Dermatitis

Sites in Los Angeles, Fountain Valley +4 more locations

Sponsor: Oneness Biotech Co., Ltd.

Sex: All·Age: 18 - 65

Code: NCT06397911·Phase 2·Recruiting·Listed May 2024

Apply to this trial